SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Larry Liebman who wrote (250)3/12/1998 11:31:00 AM
From: BulbaMan  Respond to of 4474
 
I totally agree ARIA is way undervalued. Along with the excellent points you listed, there's also been steady insider buying of ARIA in the past year (about 100,000 shares by 3 insiders).
It seems the current weakness is due to a large holder dumping its shares. When that's over (I hope real soon), the stock should quickly rebound.
Any further comments on ARIA would be appreciated.



To: Larry Liebman who wrote (250)3/13/1998 3:19:00 AM
From: Jongmans  Read Replies (1) | Respond to of 4474
 
More information on ARIAD.

ARIAD's 10 K-report 1997 is available now. If you want to be completely informed take the full version at EDGAR (access via ARIAD's site: ariad.com ), and not the abbreviated version at Yahoo! It is interesting reading-matter and gives a lot of information on this very interesting company.

Martin


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News